On the recordFebruary 8, 2012
Now, one obstacle for ensuring comparable inspections of domestic and foreign facilities is a lack of complete and accurate information that FDA has on generic drug manufacturing establishments.
Source
congress.govNow, one obstacle for ensuring comparable inspections of domestic and foreign facilities is a lack of complete and accurate information that FDA has on generic drug manufacturing establishments.
Dingell identifies lack of information as a barrier to effective inspections.
Share
More from John Dingell
Premiums are below the levels predicted by the Congressional Budget Office, and the agency has once again reiterated that the Affordable Care Act has slowed inflation and saved billions of dollars.
Gallup just found that the percentage of Americans who do not have health insurance fell to 13.4 percent.
I want to compliment the gentleman from Arizona for his tireless leadership on behalf of his constituents.